By Cole Bunn, Senior Research Analyst, LSN
Healthcare IT entrepreneurs, as opposed to biotech/medtech entrepreneurs, enjoy some favorable realities when it comes to successfully launching and sustaining a new venture. However, even though software and healthcare IT companies require far less capital than a biopharmaceutical product or medical device to get up and running, investors tend to place an emphasis on market penetration and traction, often the rate limiting step for these startups. A key to overcoming this hurdle is healthy ecosystem with innovative institutions willing to put programs in place to help new digital health technologies enter the marketplace and refine their product.
Canada is embracing digital health and the impact it can have on the public, patients and the healthcare system at large. Toronto, as the epicenter of Canadian healthcare and innovation, is naturally working to catalyze venture creation in healthcare IT and will host the RESI conference and a panel of venture investors active in the space.
The session will feature the following investors:
- Sam Ifergan, President & Managing Partner, iGan Partners
- Aaron Nelson, General Partner, dRx Capital
- Richard Osborn, Managing Partner, TELUS Ventures
- Samer Abughannam, Vice President, Persistence Capital Partners
- Sid Paquette, Managing Director, OMERS Ventures
By registering for RESI on MaRS, you’ll be able to listen to the Healthcare IT panel live, interact with the investors and experience numerous opportunities to expand your network.